The status of plasma therapy as cancer treatment
DR Parkinson
JCO Feb 1 1988: 189–190. [PDF]
The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia
GK Rivera
JCO Feb 1 1988: 191–193. [PDF]
Chromosome abnormalities in leukemia
JD Rowley
JCO Feb 1 1988: 194–202. [PDF]
	Protein A immunoadsorption in the treatment of malignant disease
	GL Messerschmidt, DH Henry, HW Snyder, Jr, J Bertram, A Mittelman, S Ainsworth, J Fiore, MV Viola, J Louie, and E Ambinder
	JCO Feb 1 1988: 203–212. [Abstract] [PDF]
	Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen
	AD Ho, T Lipp, G Ehninger, HJ Illiger, P Meyer, M Freund, and W Hunstein
	JCO Feb 1 1988: 213–217. [Abstract] [PDF]
	Short-term therapy for acute myelogenous leukemia
	AZ Rohatiner, WM Gregory, R Bassan, MJ Barnett, J Waxman, MA Richards, TS Ganesan, J Tucker, ST Malik, and R Biruls
	JCO Feb 1 1988: 218–226. [Abstract] [PDF]
	Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission
	JP Vernant, G Marit, D Maraninchi, D Guyotat, M Kuentz, C Cordonnier, and J Reiffers
	JCO Feb 1 1988: 227–231. [Abstract] [PDF]
	The characteristics and outcome of patients with late relapse acute myelogenous leukemia
	HM Kantarjian, MJ Keating, RS Walters, KB McCredie, and EJ Freireich
	JCO Feb 1 1988: 232–238. [Abstract] [PDF]
	Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors
	P Carde, JM Burgers, M Henry-Amar, M Hayat, W Sizoo, E Van der Schueren, M Monconduit, EM Noordijk, J Lustman-Marechal, and A Tanguy
	JCO Feb 1 1988: 239–252. [Abstract] [PDF]
	Chemotherapy following surgery for stages IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract
	FA Shepherd, WK Evans, G Kutas, JC Yau, P Dang, JG Scott, HA Farquharson, WH Francombe, D Bailey, and MA Baker
	JCO Feb 1 1988: 253–260. [Abstract] [PDF]
	Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study
	M Perloff, GJ Lesnick, A Korzun, F Chu, JF Holland, MP Thirlwell, RR Ellison, RW Carey, L Leone, and V Weinberg
	JCO Feb 1 1988: 261–269. [Abstract] [PDF]
	Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors
	DM Gershenson
	JCO Feb 1 1988: 270–275. [Abstract] [PDF]
	Chemotherapy for breast cancer decreases plasma protein C and protein S
	JS Rogers, 2d, AJ Murgo, JA Fontana, and PC Raich
	JCO Feb 1 1988: 276–281. [Abstract] [PDF]
	Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer
	ML Friedlander, DW Hedley, C Swanson, and P Russell
	JCO Feb 1 1988: 282–290. [Abstract] [PDF]
	Emergency laparotomy for spontaneous intestinal and colonic perforations in cancer patients receiving corticosteroids and chemotherapy
	MH Torosian and AD Turnbull
	JCO Feb 1 1988: 291–296. [Abstract] [PDF]
	Patterns of failure in primary testicular non-Hodgkin's lymphoma
	JA Martenson, Jr, SJ Buskirk, DM Ilstrup, PM Banks, RG Evans, JP Colgan, and JD Earle
	JCO Feb 1 1988: 297–302. [Abstract] [PDF]
	Successful treatment of pure endodermal sinus tumors in adult men
	CD Chong, CJ Logothetis, AC von Eschenbach, AG Ayala, and ML Samuels
	JCO Feb 1 1988: 303–307. [Abstract] [PDF]
	Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development
	ME Horowitz, E Etcubanas, ML Christensen, JA Houghton, SL George, AA Green, and PJ Houghton
	JCO Feb 1 1988: 308–314. [Abstract] [PDF]
	Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation
	RK Mulhern, AL Wasserman, D Fairclough, and J Ochs
	JCO Feb 1 1988: 315–320. [Abstract] [PDF]
	Factors affecting the prognosis of primary liver carcinoma
	FM Sutton, NC Russell, VF Guinee, and E Alpert
	JCO Feb 1 1988: 321–328. [Abstract] [PDF]
	Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response
	K Winkler, G Beron, G Delling, U Heise, H Kabisch, C Purfurst, J Berger, J Ritter, H Jurgens, and V Gerein
	JCO Feb 1 1988: 329–337. [Abstract] [PDF]
	The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group
	JR Wood, SB Green, and WR Shapiro
	JCO Feb 1 1988: 338–343. [Abstract] [PDF]
	Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism
	ML Sherman, DR Spriggs, KA Arthur, K Imamura, E Frei, 3d, and DW Kufe
	JCO Feb 1 1988: 344–350. [Abstract] [PDF]
	Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases
	JL Grem, DF Hoth, B Leyland-Jones, SA King, RS Ungerleider, and RE Wittes
	JCO Feb 1 1988: 351–379. [Abstract] [PDF]
	Photodynamic therapy
	MJ Manyak, A Russo, PD Smith, and E Glatstein
	JCO Feb 1 1988: 380–391. [Abstract] [PDF]
Surgical controversies in melanoma
CM Balch
JCO Feb 1 1988: 392–393. [PDF]
Rational for "eight-in-one" chemotherapy
HS Friedman
JCO Feb 1 1988: 393–395. [PDF]
Therapy-related acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11) (p21;q23) or a normal karyotype: a separate entity?
J Pedersen-Bjergaard, P Philip, V Ravn, SW Hansen, and NI Nissen
JCO Feb 1 1988: 395–397. [PDF]
The detection of bone marrow involvement in small-cell lung cancer using magnetic resonance imaging
V Trillet, D Revel, R Loire, J Pages, M Favrot, A Bonmartin, G Salles, P Marion, JF Mornex, and JF Cordier
JCO Feb 1 1988: 397–398. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.